Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer
Public ClinicalTrials.gov record NCT07226102. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An E-Health Intervention for Fear of Progression in Women With Gynecologic or Breast Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This clinical trial tests feasibility, acceptability and how well a virtual mental health intervention, compared to enhanced usual care consisting of an educational intervention, works to address fear of progression for women with high risk or stage III-IV gynecologic or breast cancer. Worrying about cancer coming back or progression is natural for cancer patients. Many cancer patients face stress and uncertainty as they live longer and attend regular check-ups. A supportive program can help to develop skills to feel calmer and more resilient during uncertain times and better manage feelings of fear. The virtual mental health intervention may be a feasible, acceptable and effective may to address fear of progression for women with high risk or stage III-IV gynecologic or breast cancer.
Study identification
- NCT ID
- NCT07226102
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- Not listed
Conditions and interventions
Conditions
- Anatomic Stage III Breast Cancer AJCC v8
- Anatomic Stage IV Breast Cancer AJCC v8
- Endometrial Carcinoma
- Endometrial Endometrioid Adenocarcinoma
- Female Reproductive System Neoplasm
- Stage II Ovarian Cancer AJCC v8
- Stage III Ovarian Cancer AJCC v8
- Stage III Vaginal Cancer AJCC v8
- Stage III Vulvar Cancer AJCC v8
- Stage IV Ovarian Cancer AJCC v8
- Stage IV Vaginal Cancer AJCC v8
- Stage IV Vulvar Cancer AJCC v8
- Triple-Negative Breast Carcinoma
Interventions
- Behavioral Intervention Behavioral
- Educational Intervention Other
- Internet-Based Intervention Other
- Interview Other
- Survey Administration Other
- Virtual Technology Intervention Other
Behavioral · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 15, 2026
- Primary completion
- Jul 15, 2026
- Completion
- Jul 15, 2026
- Last update posted
- Feb 3, 2026
2026
United States locations
- U.S. sites
- 12
- U.S. states
- 1
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope at Arcadia | Arcadia | California | 91007 | — |
| City of Hope Medical Center | Duarte | California | 91010 | — |
| City of Hope at Irvine Lennar | Irvine | California | 92618 | — |
| City of Hope Antelope Valley | Lancaster | California | 93534 | — |
| City of Hope at Long Beach Worsham | Long Beach | California | 90808 | — |
| City of Hope at Long Beach Elm | Long Beach | California | 90813 | — |
| City of Hope Mission Hills | Mission Hills | California | 91345 | — |
| City of Hope - Santa Clarita | Santa Clarita | California | 91355 | — |
| City of Hope at Simi Valley | Simi Valley | California | 93065 | — |
| City of Hope at Thousand Oaks | Thousand Oaks | California | 91361 | — |
| City of Hope South Bay | Torrance | California | 90503 | — |
| City of Hope Upland | Upland | California | 91786 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07226102, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 3, 2026 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07226102 live on ClinicalTrials.gov.